Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pazopanib and Paclitaxel in Unresectable Stage III/IV Melanoma
NCT01107665Phase 2Completed
- Sponsor
- University of California, Irvine
- Start
- Aug 2010
- Primary completion
- Feb 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of pazopanib in melanoma, sponsored by University of California, Irvine. Started Aug 2010; status: completed.
02
Drugs
pazopanib
03
Conditions
melanoma
Beyond the preview
Go deeper on NCT01107665.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01107665.